The epidemiology of arm and hand swelling in premenopausal breast cancer survivors

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 4, 2007, Pages 775-782

  Paskett, Electra D ^a,b   Naughton, Michelle J ^c   McCoy, Thomas P ^c   Case, L Douglas ^c   Abbott, Jill M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; ARM SWELLING; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVOR; CANCER THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAND EDEMA; HEALTH SURVEY; HUMAN; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MENTAL HEALTH; MORBIDITY; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SCORING SYSTEM;

ADULT; ARM; BREAST NEOPLASMS; FEMALE; HAND; HUMANS; INCIDENCE; LYMPHEDEMA; MIDDLE AGED; PREMENOPAUSE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 34247463794     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0168     Document Type: Article

References (68)

1. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, Inc.; 2006.
2. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
3. American Cancer Society. Breast cancer facts and figures 2005-2006. Atlanta: American Cancer Society, Inc.; 2005.
4. Paskett ED, Stark NN. Lymphedema: knowledge, treatment, and impact among breast cancer survivors. Breast J 1999;5:341.
5. Guralnik JM, LaCroix AZ, Abbott RD, et al. Maintaining mobility in late life: demographic characteristics and chronic conditions. Am J Epidemiol 1993; 137:845-57.
6. Petrek JA, Pressman PI, Smith RA. Lymphedema: current issues in research and management. CA Cancer J Clin 2000;50:292-307.
7. Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D. Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat 2003;79:47-57.
8. Ozaslan C, Kuru B. Lymphedema after treatment of breast cancer. Am J Surg 2004;187:69-72.
9. Kwan W, Jackson J, Weir LM, Dingee C, McGregor G, Olivotto IA. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. J Clin Oncol 2002;20:4242-8.
10. Velanovich V, Szymanski W. Quality of life of breast cancer patients with lymphedema. Am J Surg 1999;177:184-8.
11. Kornblith AB, Herndon JE, Weiss RB, et al. Long-term adjustment of survivors of early-stage breast carcinoma, 20 years after adjuvant chemotherapy. Cancer 2003;98:679-89.
12. Petrek JA, Heelan MC. Incidence of breast carcinoma-related lymphedema. Cancer 1998;83:1776-81.
13. Swedborg I, Wallgren A. The effect of pre- and post-mastectomy radiotherapy on the degrees of edema, shoulder-joint mobility, and gripping force. Cancer 1981;47:877-81.
14. Kissin MW, Quero Della Rovere G, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br J Surg 1986;73: 580-4.
15. Gerber L, Lampert M, Wood C, et al. Comparison of pain, motion, and edema after modified radical mastectomy vs. local excision with axillary dissection and radiation. Breast Cancer Res Treat 1992;21:139-45.
16. Werner RS, McCormick B, Petrek J, et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 1991; 180:177-84.
17. Guedes Neto HI. Arm edema after treatment for breast cancer. Lymphology 1997;30:35-6.
18. Sneeuw KC, Aaronson NK, Yarnold JR, et al. Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer: relationship with psychosocial functioning. Radiother Oncol 1992;25:160-6.
19. Maunsell E, Brisson J, Deschenes L. Arm problems and psychological distress after surgery for breast cancer. Can J Surg 1993;36:315-20.
20. Passik S, Newman M, Brennan M, Holland J. Psychiatric consultation for women undergoing rehabilitation for upper-extremity lymphedema following breast cancer treatment. J Pain Symptom Manage 1993;8:226-33.
21. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
22. Balducci L, Schapira DV, Cox CE, Greenberg HM, Lyman GH. Breast cancer of the older woman: an annotated review. J Am Geriatr Soc 1991;39:1113-23.
23. Yancik R, Ries LG, Yates JW. Breast cancer in aging women: a population-based study of contrasts in stage, surgery, and survival. Cancer 1989;63: 976-81.
24. Kessler LG. The relationship between age and the incidence of breast cancer: population and screening program data. Cancer 1992;69:1896-903.
25. Anderson RT, James MK, Miller ME, Worley AS, Longino CF, Jr. The timing of change: patterns in transitions in functional status among elderly persons. J Gerontol B Psychol Sci Soc Sci 1998;53:S17-27.
26. Hull MM. Lymphedema in women treated for breast cancer. Semin Oncol Nurs 2000;16:226-37.
27. Geller BM, Vacek PM, O'Brien P, Secker-Walker RH. Factors associated with arm swelling after breast cancer surgery. J Womens Health 2003;12:921-30.
28. Warmuth M, Bowen G, Prosnitz L, Chu L, Broadwater G, Peterson B. Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 1998;83:1362-8.
29. Paskett ED, Naughton M, Robertson J, Petrek J. Lymphedema in young breast cancer survivors. Proc Am Assoc Cancer Res 2001;42:740.
30. Lin PP, Allison DC, Wainstock J, et al. Impact of axillary lymph node dissection on the therapy of breast cancer patients. J Clin Oncol 1993;11: 1536-44.
31. Bartelin H, Garavaglia G, Johansson KA, et al. Quality assurance in conservative treatment of early breast cancer: report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative groups and the EUSOMA (European Society of Mastology). Radiother Oncol 1991;22:323-6.
32. Kroman N, Jensen MB, Wohlfahrt J, Mouridsen HT, Andersen PK, Melbye M. Factors influencing the effect of age on prognosis in breast cancer: population based study. Br Med J 2000;320:474-8.
33. Talley LI, Grizzle WE, Waterbor JW, Brown D, Weiss H, Frost AR. Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women. Int J Cancer 2002;98:118-27.
34. Shapiro CL, Recht A. Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 1994;16:101-12.
35. Quivey J, Luce JM, Stewart SL, Johnston M, Banks PJ, Bloom JR. Younger women with breast cancer: patterns of care in 5 San Francisco Bay Area Counties. In: Proceedings of the American Society of Clinical Oncology; 1998; Baltimore (MD); Waverly Press 1998.
36. Osteen RT, Cady B, Friedman M, et al. Patterns of care for younger women with breast cancer. J Natl Cancer Inst Monogr 1994;16:43-6.
37. SEER Cancer statistics review, 1975-2002. Bethesda (MD): National Cancer Institute; 2005.
38. Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006;24:1045-51.
39. Armer JM, Radina ME, Porock D, Culbertson SD. Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 2003; 52:370-9.
40. Brady M, Cella D, Mo F. Reliability and validity of the functional assessment of cancer therapy-breast (FACT-B) quality of life instrument. J Clin Oncol 1997;15:974-86.
41. Ware J, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33.
42. Gandek B, Ware J, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project, International Quality of Life Assessment. J Clin Epidemiol 1998;51:1171-8.
43. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
44. Cox DR. Regression models and life tables. J R Stat Soc Ser B 1972;34: 187-220.
45. Good PI. Resampling methods. 2nd ed. New York: Springer; 2005.
46. Liang KY, Zeger SL. Longitudinal data analysis using general linear models. Biometrika 1986;73:13-22.
47. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-30.
48. Tobin MB, Lacy HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer related arm swelling. Cancer 1993;72:3248-52.
49. Woo B, Dibble SL, Piper BF, Keating SB, Weiss MC. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum 1998; 25:915-20.
50. Witte MH, Wutte CL, Mortimer PS, Jamal S. Lymphedema in the developing and developed world: contrasts and prospects. Lymphology 1988;21:242-3.
51. Kosorok MR, Omenn GS, Diehr P, Koepsell TD, Patrick DL. Restricted activity days among older adults. Am J Public Health 1992;82:1263-7.
52. Beaulac SM, McNair LA, Scott TE, La Morte WW, Kavanah MT. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 2002;137:1253-7.
53. Goffman TE, Laronga C, Wilson L, Elkins D. Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J 2004;10:405-11.
54. Hinrichs CS, Watroba NL, Rezaishiraz H, et al. Lymphedema secondary to postmastectomy radiation: incidence and risk factors. Ann Surg Oncol 2004; 11:573-80.
55. Johansson K, Ohlsson K, Ingvar C, Albertsson M, Ekdahl C. Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology 2002;35: 59-71.
56. Hu FB. Overweight and obesity in women: health risks and consequences. J Womens Health 2003;12:163-72.
57. Aronne LJ. Classification of obesity and assessment of obesity-related health risks. Obes Res 2002;10:105-15S.
58. Denmark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol 2005;23:5814-30.
59. Brown JK, Byers T, Doyle C, et al. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003;53:268-91.
60. Rock CL, Denmark-Wahnefried W. Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol 2002;20: 3302-16.
61. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol 2002;20:1128-43.
62. Nuver J, Smit AJ, Postma A, Sleijfer DT, Gietema JA. The metabolic syndrome in long-term cancer survivors: an important target for secondary measures. Cancer Treat Rev 2002;28:195-214.
63. Argiles JM, Lopez-Soriano FJ. Insulin and cancer. Int J Oncol 2001;18:683-7.
64. Petrek JA, Senie RT, Peters M, Rosen PP. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001;92:1368-77.
65. Schijven MP, Vingerhoets AJJM, Rutten HJT, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003;29:341-50.
66. Deo SVS, Ray S, Rath GK, et al. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer 2004;41: 8-12.
67. Pereira de Godoy JM, Braile DM, de Fatima Godoy M, Longo O, Jr. Quality of life and peripheral lymphedema. Lymphology 2002;35:72-5.
68. Pain SJ, Vowler SL, Purushotham AD. Is physical function a more appropriate measure than volume excess in the assessment of breast cancer-related lymphoedema (BCRL)? Eur J Cancer 2003;39:2168-72.